维普期刊资源整合服务平台（V6.5）

222篇 您的检索式：作者名="Mazzotta"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	PACK-CXL: Corneal cross-linking in infectious keratitis显示文摘Background:Corneal cross-linking(CXL)using ultraviolet light-A(UV-A)and riboflavin is a technique developed in the 1990’s to treat corneal ectatic disorders such as keratoconus.It soon became the new gold standard in multiple countries around the world to halt the progression of this disorder,with good long-term outcomes in keratometry reading and visual acuity.The original Dresden treatment protocol was also later on used to stabilize iatrogenic corneal ectasia appearing after laser-assisted in situ keratomileusis(LASIK)and photorefractive keratectomy(PRK).CXL efficiently strengthened the cornea but was also shown to kill most of the keratocytes within the corneal stroma,later on repopulated by those cells.Review:Ultraviolet-light has long been known for its microbicidal effect,and thus CXL postulated to be able to sterilize the cornea from infectious pathogens.This cytotoxic effect led to the first clinical trials using CXL to treat advanced infectious melting corneal keratitis.Patients treated with this technique showed,in the majority of cases,a stabilization of the melting process and were able to avoid emergentàchaud keratoplasty.Following those primary favorable results,CXL was used to treat beginning bacterial keratitis as a first-line treatment without any adjunctive antibiotics with positive results for most patients.In order to distinguish the use of CXL for infectious keratitis treatment from its use for corneal ectatic disorders,a new term was proposed at the 9th CXL congress in Dublin to rename its use in infections as photoactivated chromophore for infectious keratitis-corneal collagen cross-linking(PACK-CXL).Conclusion:PACK-CXL is now more frequently used to treat infections from various infectious origins.The original Dresden protocol is still used for this purpose.Careful modifications of this protocol could improve the efficiency of this technique in specific clinical situations regarding certain types of pathogens.	David Tabibian Cosimo Mazzotta Farhad Hafezi	2016	Eye and Vision2016，3，1：	2
2	Natural resource damage assessment: The role of resource restoration显示文摘	Mazzotta MA Opaluch JJ Grigalunas TA	1994	Natural Resources J1994，，34：	1
3	Different cytokine levels in thrombolysis patients as predictors for clinical outcome显示文摘	Mazzotta G Sarchielli P Caso V	2004	Eur J Neurol2004，11，：	1
4	Circulating levels of nitrated apolipoprotein A-1 are increased in type 2 diabetic patients显示文摘	Hermo R Mier C Mazzotta M	2005	Clin Chem Lab Med2005，43，6：	1
5	Birth defects afler maternal exposure to corticosteroids:prospective cohort study and meta-analysis of epidemiological studies显示文摘	Park-Wyllie L Mazzotta P Pastuszak A	2000	Teratology2000，62，6：	1
6	Influence of shrinkage reducing admixtures on development of plastic shrinkage cracks显示文摘	Lura P Pease B Mazzotta G B	2007	ACI Materials Journal2007，104，2：	1
7	Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen ; uhrastructural analysis by Heidelberg retinal tomograph Ⅱ in vivo confocal microscopy in humans显示文摘	Mazzotta C Balestrazzi A Traversi C	2007	Cornea2007，26，4：	1
8	Dysphagia following stroke 显示文摘	Paciaroin M Mazzotta G Corea F	2004	Eur Neurol2004，51，3：	1
9	Dysphagia following stroke显示文摘	Paciaroni M Mazzotta G Corea F	2004	Eur Neurol2004，51，1：	1
10	Riboflavin and ultraviolet A collagen crosslinking: in vivo thermographic analysis of the corneal surface 显示文摘	Mencucci R Mazzotta C Rossi F	2007	J Cataract Refract Surg2007，33，6：	1
11	Gastric motor ab- normalities in diabetic and postvagotomy gastroparesis= effect of metoclopramide and bethanechol显示文摘	Malagelada JR Rees WD Mazzotta LJ	1980	Gastroenterology1980，78，2：	1
12	Thermal inactivation of stationary - phase and acid - adapted escherichia coli O157:H7, salmonella, and Listeria monocytogenes in fruit juices显示文摘	Mazzotta A S	2001	Joumal Food Prot2001，64，：	1
13	Dysphagia following stroke 显示文摘	Paciaroni M Mazzotta G Corea F	2004	Eur Neurol2004，51，3：	1
14	Long-term experience with etanercept in psoriatic arthritis patients:A 3-year observational study显示文摘	Mazzotta A Esposito M Schipani C	2009	J Dermatolog Treat2009，20，6：	1
15	The third component of the complement (C3) is a marker of the risk of atherogenesis显示文摘	Vincenzo Capuano Teodora D'Arminio Giuseppe La Sala Gianfranco Mazzotta	2006	European Journal of Cardiovascular Prevention & Rehabilitation2006，，4：	1
16	Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy:the Siena eye cross study显示文摘	Caporossi A Mazzotta C Baiocchi S	2010	Am J Ophthalmol2010，149，：	1
17	Inhibiting proliferation in KB cancer cell by RNA interference-mediated knowdown of nicotinamide N-Methyltransferase expression显示文摘	Pozzi Vs Mazzotta Mj Lo Muzio L	2011	Int J Immunopathol Pharmacol2011，24，1：	1
18	The renin angiotensin system in the development of cardiovascular disease:role of aliskiren in risk reduction 显示文摘	Verdecchia P Angeli F Mazzotta G	2008	Vasc Health Risk Manag2008，4，5：	1
19	Dysphagiafollow- ing stroke显示文摘	Paciaroni M Mazzotta G Corea F	2004	Eur Neurol2004，51，3：	1
20	Parasurgical therapy for keratoconus by rlboflavin-uhraviolet type A rays induced cross-linking of corneal collagen : preliminary refractive results in an Italian study 显示文摘	Caporossi A Baiocchi S Mazzotta C	2006	J Cataract Refract Surg2006，32，5：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示